Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Neoplasms 1 Mastocytosis, Systemic 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Hairy Cell 1 Kidney Neoplasms 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Emergence Delirium 1 Delirium 1 Cachexia 1 Burkitt Lymphoma 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Anus Neoplasms 1

Interventions

anamorelin 1 alkaloid GB18 1 Standard of Care 1 Retrospective Studies 1 Olanzapine 1 Ibuprofen 1 Fecal Microbiota Transplantation 1 Enteral Nutrition 1 Dietary Supplements 1 Counseling 1 Carnitine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Ibuprofen × 1 year × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡